Mid-market RCM company
$8M ARR, $3M active pipeline
- Reporting Period
- Week of May 11-15, 2026
- Prepared By
- PipelineIQ
- Delivered
- Monday 8:00 AM ET
- Brief ID
- sample-rcm-2026-w19
Executive Summary
Pipeline coverage remains below target for the next two quarters despite strong late-stage deal concentration.
Current weighted forecast indicates moderate risk to Q3 attainment due to deal concentration, MEDDPICC gaps, and extended procurement cycles within hospital systems.
Forecast appears overstated by $350K-$500K based on historical conversion patterns.
Key concerns
- ●38% of pipeline value tied to only 3 opportunities.
- ●Forecast confidence declined from 74 to 67 over the past 30 days.
- ●Economic Buyer engagement missing in 41% of Stage 3+ opportunities.
- ●Average sales cycle has increased from 94 to 117 days.
- ●One large deal likely slipping into next quarter due to legal/procurement delays.
Positive indicators
- ●Win rate on properly qualified opportunities remains high (32%).
- ●Strong momentum in outsourced coding and denial management offerings.
- ●Expansion pipeline growing within existing customer base.
- ●SDR-generated opportunities outperforming marketing-sourced deals by 2.1x conversion rate.
Executive KPI Snapshot
| Metric | Current | Target | Trend | Executive Insight |
|---|---|---|---|---|
| Quarterly Pipeline Coverage | 2.3x | 3.5x | ↓ | Pipeline generation risk |
| Weighted Forecast | $1.84M | $2.0M | ↓ | Slightly behind plan |
| Forecast Confidence Score | 67/100 | 85+ | ↓ | Qualification inconsistency |
| MEDDPICC Compliance | 61% | 85% | ↓ | Major gap in late-stage rigor |
| Average Deal Size | $118K | $100K | ↑ | Larger strategic deals |
| Win Rate | 24% | 30% | → | Qualification improvement needed |
| Avg Sales Cycle | 117 days | <95 days | ↓ | Procurement delays increasing |
| Executive Engagement Rate | 44% | 70% | ↓ | Leadership access lacking |
Pipeline Inspection Summary
Total pipeline: $3M
Pipeline health findings
- ▸27% of opportunities have had no executive contact in 30+ days.
- ▸19% of opportunities have stale close dates.
- ▸34% of pipeline lacks a documented compelling event.
- ▸Multiple deals showing "happy ears forecasting" behavior from AEs.
Forecast Confidence Analysis
Confidence Score
67/100
Target: 85+. Trend: declining over 30 days.
Positive signals
- Strong historical retention rates
- Existing customer expansions
- Larger average deal sizes
- Strong demo-to-proposal conversion
- High engagement from VP-level buyers
Negative signals
- Economic buyer missing on 5 of top 12 deals
- No procurement timeline on top opportunities
- MEDDPICC gaps in late-stage deals
- Stalled legal reviews
- Forecast pushed multiple times
MEDDPICC Compliance Scoring
Overall compliance: 61% (target 85%)
Major risks
- Economic buyer not confirmed in 5 of top 12 opportunities.
- Procurement / paper process undocumented in most hospital opportunities.
- Several "champions" appear to be users, not true internal mobilizers.
Positive findings
- Pain is generally well identified.
- Financial / ROI positioning strong in denial management opportunities.
- Expansion deals have materially stronger qualification rigor.
Top Deals Analysis
Northeast Regional Health System
Deal size
$420K ARR
Offering
Outsourced Coding + AI QA Automation
Stage
Procurement · Best Case
PipelineIQ assessment
- ·Strong clinical and operations support.
- ·CFO not fully engaged.
- ·Legal review delayed due to BA agreement revisions.
- ·Procurement timeline not confirmed.
Recommended executive action
CEO / CRO executive outreach to CFO within 7 days to reinforce ROI and implementation timeline urgency.Multi-State Orthopedic Group
Deal size
$285K ARR
Offering
Denial Management Services
Stage
Proposal
PipelineIQ assessment
- ·Strong champion.
- ·Compelling event tied to payer audit exposure.
- ·Competitor aggressively discounting.
- ·No documented procurement process.
Recommended executive action
Introduce implementation leader and customer reference call immediately to increase switching confidence.Community Hospital Network
Deal size
$510K ARR
Offering
Full Revenue Cycle Outsourcing
Stage
Discovery
PipelineIQ assessment
- ·Executive engagement declining.
- ·Multiple close-date pushes.
- ·MEDDPICC completeness only 42%.
- ·AE optimism materially exceeds engagement signals.
Recommended executive action
Requalify opportunity immediately. Remove from commit forecast unless procurement process and executive sponsor are validated.Executive Recommendations
Conduct Executive Deal Reviews
Focus only on the top 10 opportunities, any deal >$150K ARR, or any opportunity forecasted within 60 days.
Remove Weak Deals from Commit Forecast
Current commit appears inflated by $350K-$500K from unvalidated procurement assumptions, missing executive engagement, and poor paper process visibility.
Increase Executive Buyer Engagement
CRO in top 5 opportunities weekly. CEO in any deal >$250K. Formal executive sponsor mapping.
Improve MEDDPICC Discipline
No Stage 3 advancement without Economic Buyer identified. Mandatory paper process documentation. Champion validation scoring added to pipeline reviews.
Address Pipeline Coverage Gap
Increase outbound SDR focus on community hospitals and orthopedic groups. Launch customer expansion campaign. Re-engage stalled opportunities from prior 6 months.
Top 10 Executive Priorities
| # | Priority | Owner | Timeline |
|---|---|---|---|
| 01 | Requalify all Commit deals | CRO | This Week |
| 02 | CEO outreach to Northeast Health CFO | CEO | 3 Days |
| 03 | Add procurement checkpoints to forecast reviews | RevOps | Immediate |
| 04 | Audit stale close dates | Sales Leadership | This Week |
| 05 | Launch expansion pipeline initiative | Customer Success | 2 Weeks |
| 06 | Create executive sponsor program | CRO | 30 Days |
| 07 | Implement MEDDPICC score gating | RevOps | Immediate |
| 08 | Build hospital procurement risk dashboard | RevOps | 2 Weeks |
| 09 | Increase SDR outreach to orthopedic market | SDR Leader | Immediate |
| 10 | Review forecast methodology accuracy | Executive Team | Monthly |
Executive bottom line
The company has a credible path to quarterly attainment, but current forecasts are overstated due to qualification gaps and overreliance on late-stage assumptions. The primary operational issue is not pipeline volume alone - it is forecast discipline and executive qualification rigor. If leadership aggressively tightens deal qualification and increases executive engagement over the next 30 to 45 days, forecast predictability and close rates should materially improve entering the next quarter.
This brief was generated from anonymized sample data. Your weekly brief is built from your live CRM, call intelligence, and engagement signals.